Mackenzie Investments ("Mackenzie") today released its 2025 ETF Outlook (the "Outlook"), examining the growth of the exchange-traded funds ("ETF") industry in Canada throughout 2024 and identifying ...

In our Energy Outlook, we detail our forecasts on fossil fuel, renewables, carbon capture and storage, hydrogen, and utilities ...

Fintel reports that on January 21, 2025, Cantor Fitzgerald downgraded their outlook for Keros Therapeutics (NasdaqGM:KROS) ...

Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases like ulcerative colitis. Read the pre-IPO report here.

H.C. Wainwright maintained a positive outlook on Axsome Therapeutics (NASDAQ:AXSM), reiterating a Buy stock rating with a ...

The Bitcoin market continues to see a lot of noisy trading, but more than anything else, this is a market that will continue to see buyers on dips, as the market remains very stout overall. At this ...

Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company developing therapies to surmount current cancer drug resistance and immune suppression, provides an overview of key ...